Opposing roles of B lymphocyte subsets in atherosclerosis

References

• Kyaw, T., P. Tipping, B. H. Toh, and A. Bobik. 2011. Current understanding of the role of B cell subsets and intimal and adventitial B cells in atherosclerosis. Curr. Opin. Lipidol. 22: 373–379
   PubMed Web of Science ®Google Scholar
• Kyaw, T., P. Tipping, A. Bobik, and B. H. Toh. 2012. Protective role of natural IgM-producing B1a cells in atherosclerosis. Trends Cardiovasc. Med. 22: 48–53
   PubMed Web of Science ®Google Scholar
• Hansson, G. K. 2002. The B cell: a good guy in vascular disease? Arterioscler. Thromb. Vasc. Biol. 22: 523–524
   PubMed Web of Science ®Google Scholar
• Kyaw, T., C. Tay, A. Khan, et al 2010. Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis. J. Immunol. 185: 4410–4419
   PubMed Web of Science ®Google Scholar
• Kyaw, T., C. Tay, H. Hosseini, et al 2012. Depletion of B2 but not B1a B cells in BAFF receptor-deficient ApoE(−/−) mice attenuates atherosclerosis by potently ameliorating arterial inflammation. PLoS One 7: e29371
   PubMed Web of Science ®Google Scholar
• Kyaw, T., P. Cui, C. Tay, et al 2013. BAFF receptor mAb treatment ameliorates development and progression of atherosclerosis in hyperlipidemic ApoE(-/-) mice. PLoS One 8: e60430
   PubMed Web of Science ®Google Scholar
• Ait-Oufella, H., O. Herbin, J. D. Bouaziz, et al 2010. B cell depletion reduces the development of atherosclerosis in mice. J. Exp. Med. 207: 1579–1587
   PubMed Web of Science ®Google Scholar
• Sage, A. P., D. Tsiantoulas, L. Baker, et al 2012. BAFF receptor deficiency reduces the development of atherosclerosis in mice-brief report. Arterioscler. Thromb. Vasc. Biol. 32: 1573–1576
   PubMed Web of Science ®Google Scholar
• Yla-Herttuala, S., W. Palinski, S. W. Butler, et al 1994. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL. Arterioscler. Thromb. 14: 32–40
   PubMed Web of Science ®Google Scholar
• Tsiantoulas, D., C. J. Diehl, J. L. Witztum, and C. J. Binder. 2014. B cells and humoral immunity in atherosclerosis. Circ. Res. 114: 1743–1756
   PubMed Web of Science ®Google Scholar
• Mayr, M., S. Kiechl, J. Willeit, G. Wick, and Q. Xu. 2000. Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 102: 833–839
   PubMed Web of Science ®Google Scholar
• Wick, G., B. Jakic, M. Buszko, et al 2014. The role of heat shock proteins in atherosclerosis. Nat. Rev. Cardiol. 11: 516–529
   PubMed Web of Science ®Google Scholar
• Lamb, D. J., W. El-Sankary, and G. A. Ferns. 2003. Molecular mimicry in atherosclerosis: a role for heat shock proteins in immunisation. Atherosclerosis 167: 177–185
   PubMed Web of Science ®Google Scholar
• Nurieva, R. I., Y. Chung, G. J. Martinez, et al 2009. Bcl6 mediates the development of T follicular helper cells. Science 325: 1001–1005
   PubMed Web of Science ®Google Scholar
• Vinuesa, C. G., M. A. Linterman, D. Yu, and I. C. MacLennan. 2016. Follicular helper T cells. Annu. Rev. Immunol. 34: 335–368
   PubMed Web of Science ®Google Scholar
• Constant, S. L. 1999. B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo. J. Immunol. 162: 5695–5703
   PubMed Web of Science ®Google Scholar
• Falcone, M., J. Lee, G. Patstone, et al 1998. B lymphocytes are crucial antigen-presenting cells in the pathogenic autoimmune response to GAD65 antigen in nonobese diabetic mice. J. Immunol. 161: 1163–1168
   PubMed Web of Science ®Google Scholar
• Tangye, S. G., C. S. Ma, R. Brink, and E. K. Deenick. 2013. The good, the bad and the ugly - TFH cells in human health and disease. Nat. Rev. Immunol. 13: 412–426
   PubMed Web of Science ®Google Scholar
• Tellier, J., W. Shi, M. Minnich, et al 2016. Blimp-1 controls plasma cell function through the regulation of immunoglobulin secretion and the unfolded protein response. Nat. Immunol. 17: 323–330
   PubMed Web of Science ®Google Scholar
• Cannons, J. L., H. Qi, K. T. Lu, et al 2010. Optimal germinal center responses require a multistage T cell:B cell adhesion process involving integrins, SLAM-associated protein, and CD84. Immunity 32: 253–265
   PubMed Web of Science ®Google Scholar
• Crotty, S., E. N. Kersh, J. Cannons, et al 2003. SAP is required for generating long-term humoral immunity. Nature 421: 282–287
   PubMed Web of Science ®Google Scholar
• Lund, F. E. 2008. Cytokine-producing B lymphocytes-key regulators of immunity. Curr. Opin. Immunol. 20: 332–338
   PubMed Web of Science ®Google Scholar
• Tay, C., Y.-H. Liu, H. Hosseini, et al 2016. B cell-specific depletion of TNFα inhibits atherosclerosis development and plaque vulnerability to rupture by reducing cell death and inflammation. Cardiovasc. Res. 111:385–397
   PubMed Web of Science ®Google Scholar
• Houtkamp, M. A., O. J. de Boer, C. M. van der Loos, et al 2001. Adventitial infiltrates associated with advanced atherosclerotic plaques: structural organization suggests generation of local humoral immune responses. J. Pathol. 193: 263–269
   PubMed Web of Science ®Google Scholar
• Mohanta, S. K., C. Yin, L. Peng, et al 2014. Artery tertiary lymphoid organs contribute to innate and adaptive immune responses in advanced mouse atherosclerosis. Circ. Res. 114: 1772–1787
   PubMed Web of Science ®Google Scholar
• Grabner, R., K. Lotzer, S. Dopping, et al 2009. Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice. J. Exp. Med. 206: 233–248
   PubMed Web of Science ®Google Scholar
• Clement, M., K. Guedj, F. Andreata, et al 2015. Control of the T follicular helper-germinal center B-cell axis by CD8(+) regulatory T cells limits atherosclerosis and tertiary lymphoid organ development. Circulation 131: 560–570
   PubMed Web of Science ®Google Scholar
• Linterman, M. A., W. Pierson, S. K. Lee, et al 2011. Foxp3+ follicular regulatory T cells control the germinal center response. Nat. Med. 17: 975–982
   PubMed Web of Science ®Google Scholar
• Campbell, K. A., M. J. Lipinski, A. C. Doran, et al 2012. Lymphocytes and the adventitial immune response in atherosclerosis. Circ. Res. 110: 889–900
   PubMed Web of Science ®Google Scholar
• Hu, D., S. K. Mohanta, C. Yin, et al 2015. Artery tertiary lymphoid organs control aorta immunity and protect against atherosclerosis via vascular smooth muscle cell lymphotoxin beta receptors. Immunity 42: 1100–1115
   PubMed Web of Science ®Google Scholar
• Srikakulapu, P., D. Hu, C. Yin, et al 2016. Artery tertiary lymphoid organs control multilayered territorialized atherosclerosis B-cell responses in aged ApoE-/- mice. Arterioscler. Thromb. Vasc. Biol. 36: 1174–1185
   PubMed Web of Science ®Google Scholar
• Baumgarth, N. 2013. Innate-like B cells and their rules of engagement. Adv. Exp. Med. Biol. 785: 57–66
   PubMed Web of Science ®Google Scholar
• Baumgarth, N. 2011. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11: 34–46
   PubMed Web of Science ®Google Scholar
• Wang, H., J. E. Coligan, and H. C. Morse III. 2016. Emerging functions of natural IgM and its Fc receptor FCMR in immune homeostasis. Front. Immunol. 7: 99
   PubMed Web of Science ®Google Scholar
• Baumgarth, N., E. E. Waffarn, and T. T. Nguyen. 2015. Natural and induced B-1 cell immunity to infections raises questions of nature versus nurture. Ann. N. Y. Acad. Sci. 1362: 188–199
   PubMed Web of Science ®Google Scholar
• Kyaw, T., C. Tay, S. Krishnamurthi, et al 2011. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ. Res. 109: 830–840
   PubMed Web of Science ®Google Scholar
• Wardemann, H., T. Boehm, N. Dear, and R. Carsetti. 2002. B-1a B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J. Exp. Med. 195: 771–780
   PubMed Web of Science ®Google Scholar
• Ehrenstein, M. R. and C. A. Notley. 2010. The importance of natural IgM: scavenger, protector and regulator. Nat. Rev. Immunol. 10: 778–786
   PubMed Web of Science ®Google Scholar
• Rosenfeld, S. M., H. M. Perry, A. Gonen, et al 2015. B-1b cells secrete atheroprotective IgM and attenuate atherosclerosis. Circ. Res. 117: e28–e39
   PubMed Web of Science ®Google Scholar
• Hosseini, H., Y. Li, P. Kanellakis, et al 2015. Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes. Cardiovasc. Res. 106: 443–452
   PubMed Web of Science ®Google Scholar
• Silverman, G. J. 2015. Protective natural autoantibodies to apoptotic cells: evidence of convergent selection of recurrent innate-like clones. Ann. NY Acad. Sci. 1362: 164–175
   PubMed Web of Science ®Google Scholar
• Grasset, E. K., A. Duhlin, H. E. Agardh, et al 2015. Sterile inflammation in the spleen during atherosclerosis provides oxidation-specific epitopes that induce a protective B-cell response. Proc. Natl. Acad. Sci. USA 112: E2030–E2038
   PubMed Web of Science ®Google Scholar
• Hoffmann, A., S. Kerr, J. Jellusova, et al 2007. Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population. Nat. Immunol. 8: 695–704
   PubMed Web of Science ®Google Scholar
• Jellusova, J., S. Duber, E. Guckel, et al 2010. Siglec-G regulates B1 cell survival and selection. J. Immunol. 185: 3277–3284
   PubMed Web of Science ®Google Scholar
• Griffin, D. O., N. E. Holodick, and T. L. Rothstein. 2011. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70-. J. Exp. Med. 208: 67–80
   PubMed Web of Science ®Google Scholar
• Wenig, K., L. Chatwell, U. von Pawel-Rammingen, et al 2004. Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG. Proc. Natl Acad. Sci. USA 101: 17371–17376
   PubMed Web of Science ®Google Scholar
• Winstedt, L., S. Jarnum, E. A. Nordahl, et al 2015. Complete removal of extracellular IgG antibodies in a randomized dose-escalation phase I study with the bacterial enzyme IdeS–a novel therapeutic opportunity. PLoS One 10: e0132011
   PubMed Web of Science ®Google Scholar
• Nandakumar, K. S., B. P. Johansson, L. Bjorck, and R. Holmdahl. 2007. Blocking of experimental arthritis by cleavage of IgG antibodies in vivo. Arthritis Rheum. 56: 3253–3260
   PubMed Web of Science ®Google Scholar
• Munch, G., V. Boivin-Jahns, H. P. Holthoff, et al 2012. Administration of the cyclic peptide COR-1 in humans (phase I study): ex vivo measurements of anti-beta1-adrenergic receptor antibody neutralization and of immune parameters. Eur. J. Heart Fail. 14: 1230–1239
   PubMed Web of Science ®Google Scholar
• Cardilo-Reis, L., S. Gruber, S. M. Schreier, et al 2012. Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype. EMBO Mol. Med. 4: 1072–1086
   PubMed Web of Science ®Google Scholar